Strengthening Europe's public health response to cardiovascular disease and diabetes requires shifting from reactive care to sustained life-course prevention and collaborative implementation.
Strengthening Europe's public health response to cardiovascular disease and diabetes requires shifting from reactive care to sustained life-course prevention and addressing persistent implementation gaps.
Background Cardiovascular disease and diabetes remain the leading causes of premature mortality in Europe, despite longstanding political commitments and the availability of cost-effective preventive interventions. As the global public health community approaches the 40th anniversary of the Ottawa Charter for Health Promotion, persistent gaps between prevention principles and implementation require renewed policy focus. Analysis This policy brief synthesises evidence from international reports and European initiatives to examine why prevention efforts for cardiovascular disease and diabetes have not achieved sufficient scale or impact. It highlights the role of obesity, diabetes, and early-life risk exposure in shaping cardiovascular risk, alongside fragmented surveillance systems and continued reliance on reactive, treatment-centred care. While current policy frameworks demonstrate ambition, implementation and accountability remain inconsistent. Policy Options Priority actions include embedding life-course prevention across cardiovascular and diabetes strategies, strengthening primary and community-based prevention, investing in equity-oriented surveillance, and scaling collaborative initiatives such as JACARDI and JA PreventNCD. Conclusion Achieving equitable prevention of cardiovascular disease and diabetes requires a shift from reactive care to sustained life-course prevention.
“When every country speaks the same practical language of prevention, collaboration becomes scalable.”
Sarah Cuschieri (Wed,) conducted a review in Cardiovascular disease and diabetes. Life-course prevention policies was evaluated. Strengthening Europe's public health response to cardiovascular disease and diabetes requires shifting from reactive care to sustained life-course prevention and collaborative implementation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: